Cetraxal 0.2 % Otic Solution
RxNorm 848960
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 848960 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cetraxal 0.2 % Otic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Cetraxal 0.2 % (as ciprofloxacin HCl) Otic Solution
(Atom ID: 6812559)
PSNPrescribable
Prescribable Name (PSN):
Cetraxal 0.2 % Otic Solution
(Atom ID: 6406178)
SYPrescribable
Synonym (SY):
Cetraxal 0.2 % Otic Solution
(Atom ID: 2978485)
SYPrescribable
Synonym (SY):
Cetraxal 2 mg/ML Otic Solution
(Atom ID: 2968589)
SBDPrescribable
Semantic Branded Drug (SBD):
Ciprofloxacin 2 mg/ML Otic Solution [Cetraxal]
(Atom ID: 12358565)
Patient Education
Ciprofloxacin Otic
Ciprofloxacin otic solution (Cetraxal) and ciprofloxacin otic suspension (Otiprio) are used to treat outer ear infections in adults and children. Ciprofloxacin otic suspension (Otiprio) is also used in children during ear tube placement surgery to prevent infection or ear drainage. Ciprofloxacin otic is in a class of medications called quinolone antibiotics. It works by killing the bacteria that cause infection.
[Learn More]
* Please review the disclaimer below.